16-84170333-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_178452.6(DNAAF1):​c.1505C>T​(p.Pro502Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.361 in 1,613,566 control chromosomes in the GnomAD database, including 107,765 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P502P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.31 ( 7769 hom., cov: 32)
Exomes 𝑓: 0.37 ( 99996 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.826

Publications

24 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.3488226E-4).
BP6
Variant 16-84170333-C-T is Benign according to our data. Variant chr16-84170333-C-T is described in ClinVar as [Benign]. Clinvar id is 226575.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.368 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.1505C>T p.Pro502Leu missense_variant Exon 8 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.1505C>T p.Pro502Leu missense_variant Exon 8 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.307
AC:
46589
AN:
151974
Hom.:
7761
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.469
Gnomad AMR
AF:
0.366
Gnomad ASJ
AF:
0.364
Gnomad EAS
AF:
0.329
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.339
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.372
Gnomad OTH
AF:
0.318
GnomAD2 exomes
AF:
0.344
AC:
85585
AN:
248686
AF XY:
0.345
show subpopulations
Gnomad AFR exome
AF:
0.152
Gnomad AMR exome
AF:
0.384
Gnomad ASJ exome
AF:
0.357
Gnomad EAS exome
AF:
0.341
Gnomad FIN exome
AF:
0.340
Gnomad NFE exome
AF:
0.374
Gnomad OTH exome
AF:
0.349
GnomAD4 exome
AF:
0.367
AC:
535884
AN:
1461474
Hom.:
99996
Cov.:
83
AF XY:
0.364
AC XY:
264345
AN XY:
727026
show subpopulations
African (AFR)
AF:
0.151
AC:
5045
AN:
33480
American (AMR)
AF:
0.383
AC:
17125
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
9394
AN:
26136
East Asian (EAS)
AF:
0.331
AC:
13151
AN:
39696
South Asian (SAS)
AF:
0.286
AC:
24635
AN:
86248
European-Finnish (FIN)
AF:
0.339
AC:
18018
AN:
53138
Middle Eastern (MID)
AF:
0.333
AC:
1922
AN:
5768
European-Non Finnish (NFE)
AF:
0.383
AC:
425583
AN:
1111930
Other (OTH)
AF:
0.348
AC:
21011
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
23892
47783
71675
95566
119458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13372
26744
40116
53488
66860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.306
AC:
46609
AN:
152092
Hom.:
7769
Cov.:
32
AF XY:
0.306
AC XY:
22780
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.160
AC:
6628
AN:
41518
American (AMR)
AF:
0.366
AC:
5593
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
1261
AN:
3468
East Asian (EAS)
AF:
0.330
AC:
1704
AN:
5166
South Asian (SAS)
AF:
0.288
AC:
1388
AN:
4820
European-Finnish (FIN)
AF:
0.339
AC:
3593
AN:
10592
Middle Eastern (MID)
AF:
0.286
AC:
83
AN:
290
European-Non Finnish (NFE)
AF:
0.372
AC:
25272
AN:
67956
Other (OTH)
AF:
0.315
AC:
663
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1627
3253
4880
6506
8133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.358
Hom.:
21849
Bravo
AF:
0.306
TwinsUK
AF:
0.390
AC:
1445
ALSPAC
AF:
0.383
AC:
1477
ESP6500AA
AF:
0.160
AC:
700
ESP6500EA
AF:
0.370
AC:
3176
ExAC
AF:
0.338
AC:
40957
Asia WGS
AF:
0.269
AC:
933
AN:
3478
EpiCase
AF:
0.368
EpiControl
AF:
0.374

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
May 06, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro502Leu in exon 8 of DNAAF1: This variant is not expected to have clinical s ignificance because it has been identified in 37.5% (24168/64438) of European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs11644164). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Dec 10, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 13 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.29
DANN
Benign
0.23
DEOGEN2
Benign
0.0022
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0041
N
LIST_S2
Benign
0.36
T
MetaRNN
Benign
0.00083
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.81
N
PhyloP100
-0.83
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.14
N
REVEL
Benign
0.0060
Sift
Benign
0.53
T
Sift4G
Benign
0.40
T
Polyphen
0.0030
B
Vest4
0.049
MPC
0.020
ClinPred
0.00055
T
GERP RS
-0.20
Varity_R
0.019
gMVP
0.076
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11644164; hg19: chr16-84203939; COSMIC: COSV57577083; COSMIC: COSV57577083; API